Hypothalamic abnormality in patients with inflammatory demyelinating disorders

References

• Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364(9451):2106–12.
   PubMed Web of Science ®Google Scholar
• Fujihara K, Sato DK. AQP4 antibody serostatus: is its luster being lost in the management and pathogenesis of NMO. Neurology 2013;81(14):1186–8.
   PubMed Web of Science ®Google Scholar
• Kim W, Kim SH, Lee SH, et al. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler 2011;17(9):1107–12.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66(10):1485–9.
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63(7):964–8.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wu A, Zhang B, et al. Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica. Mult Scler 2014;20(4):418–23.
   PubMed Web of Science ®Google Scholar
• Qiu W, Raven S, Wu JS, et al. Hypothalamic lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry 2011;82(7):819–22.
   PubMed Web of Science ®Google Scholar
• Huitinga I, van der Cammen M, Salm L, et al. IL-1beta immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis. J Neuroimmunol 2000;107(1):8–20.
   PubMed Web of Science ®Google Scholar
• Huitinga I, De Groot CJ, Van der Valk P, et al. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 2001;60(12):1208–18.
   PubMed Web of Science ®Google Scholar
• Viegas S, Weir A, Esiri M, et al. Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2009;80(6):679–82.
   PubMed Web of Science ®Google Scholar
• Zellini F, Niepel G, Tench CR, Constantinescu CS. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis. Mult Scler 2009;15(12):1442–9.
   PubMed Web of Science ®Google Scholar
• Schumann EM, Kumpfel T, Then BF, et al. Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume. Ann Neurol 2002;51(6):763–7.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Nakashima I, Miyazawa I, et al. Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange. J Neurol 2007;254(5):670–1.
   PubMed Web of Science ®Google Scholar
• Oka Y, Kanbayashi T, Mezaki T, et al. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol 2004;251(7):885–6.
   PubMed Web of Science ®Google Scholar
• Chan KH, Tse CT, Chung CP, et al. Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol 2011;68(11):1432–9.
   PubMed Web of Science ®Google Scholar
• McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008;71(2):93–100.
   PubMed Web of Science ®Google Scholar
• Wang KC, Lee CL, Chen SY, et al. Prominent brainstem symptoms/signs in patients with neuromyelitis optica in a Taiwanese population. J Clin Neurosci 2011;18(9):1197–200.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292–302.
   PubMed Web of Science ®Google Scholar
• Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59(4):499–505.
   Google Scholar
• Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 2006;63(10):1398–400.
   PubMedGoogle Scholar
• de Seze J, Debouverie M, Zephir H, et al. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol 2007;64(10):1426–32.
   PubMedGoogle Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33(11):1444–52.
   PubMed Web of Science ®Google Scholar
• Saleem SN, Said AH, Lee DH. Lesions of the hypothalamus: MR imaging diagnostic features. Radiographics 2007;27(4):1087–108.
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63(3):390–6.
   PubMedGoogle Scholar
• Lotze TE, Northrop JL, Hutton GJ, et al. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008;122(5):e1039–47.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Fryer JP, Lennon VA, et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology 2013;81(14):1197–204.
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Debruyne J, Krecke KN, et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 2010;133(9):2626–34.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Nakamura T, Hashimoto K, et al. Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: a case report and literature review. Arch Neurol 2012;69(10):1355–9.
   PubMedGoogle Scholar
• Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 2013;80(24):2210–6.
   PubMed Web of Science ®Google Scholar
• White KD, Scoones DJ, Newman PK. Hypothermia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;61(4):369–75.
   PubMed Web of Science ®Google Scholar
• Siritho S, Apiwattanakul M, Nakashima I, et al. Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: a comparison with seropositive cases. J Neurol Sci 2014;341(1–2):17–21.
   PubMed Web of Science ®Google Scholar